MAT (macrophage activate therapy)
MAT by IMMI is formulated with high molecular weight hyaluronic acid (HMW-HA) to boost anti-cancer activities. HMW-HA has been linked to studies on longevity and cancer resistance in mammals. HMW-HA is found to stimulate the endogenous production of granulocyte colony macrophage activating factor (MAT) in healthy subjects and patients with cancer burden while low molecular weight HA does not have this immune powering effect. Combination with HMW-HA also promotes slow release of MAT.
Best in Class
Slow Release over 7 days
Activation of Endogenous MAT
No Side Effects
Contains No Human Materials
€ 390,00